Homepage | CIDRAP
WEBCIDRAP is a trusted source of information and analysis on emerging and re-emerging infectious diseases. Learn about its news, podcasts, reports, and initiatives on COVID-19, influenza, antibiotic resistance, and more.
COVID-19 - CIDRAP
WEBCIDRAP is a global resource for COVID-19 information, analysis, and guidance. Find the latest news, data, commentary, and FAQs on the pandemic, long-COVID, vaccines, and more.
About CIDRAP | CIDRAP
WEBCIDRAP is a University of Minnesota center that works to prevent and respond to public health threats from emerging infectious diseases. It conducts research, consensus building, information synthesis, communication, education, and interdisciplinary partnerships on various topics and projects.
COVID-adapted stewardship intervention linked to reduced
WEB1 day ago · Jordi Mora Igual / iStock. Incorporating COVID-19–specific elements into an existing antimicrobial stewardship program (ASP) framework was associated with reduced antibiotic use and resistance at a safety-net hospital in Chicago, researchers reported today in Antimicrobial Stewardship & Healthcare Epidemiology.. COVID-19 posed a significant diagnostic challenge for clinicians in the early ...
Study forecasts more than 39 million deaths from antimicrobial ...
WEB1 day ago · Antibiotic-resistant bacterial infections could take the lives of more than 39 million people by 2050 unless action is taken to improve healthcare quality, prevent infections, reduce inappropriate antibiotic use, and develop new antibiotics, according to a landmark new study published this week in The Lancet.. The modeling study by researchers with the Global Research on Antimicrobial ...
Global health experts note improved post-COVID pandemic
WEB2 days ago · A new survey among leading global infectious disease experts conducted by Abbott shows that most experts agree that pandemic preparedness has improved since the COVID-19 pandemic, but significant gaps remain in building surveillance programs to identify emerging pathogens, public health funding, and adequate testing infrastructure.. The Abbott Pandemic Defense Coalition asked 103 ...
COVID-19: CIDRAP Commentaries
WEBCOVID-19: The CIDRAP Viewpoint. Starting at the beginning of the pandemic, CIDRAP compiled a groundbreaking of series of reports on key aspects of COVID-19, such as what direction the pandemic might take, how to communicate risks effectively, smart testing for the virus and for antibodies to it, contact tracing, surveillance, ensuring a ...
CIDRAP to develop vaccine roadmap for future coronavirus threats
WEBOver the past few years, health groups have tapped CIDRAP to develop similar vaccine roadmaps for influenza, Zika virus, Nipah virus and Ebola/Marburg viruses. Michael T. Osterholm, PhD, MPH, CIDRAP's director, said current COVID-19 vaccines may not protect against future SARS-CoV-2 variants, and the threat of a novel virus spillover looms in ...
News Scan for Sep 24, 2021 - CIDRAP
WEBSep 24, 2021 · COVID-19 vaccine hesitancy has decreased, survey says. Of 1,061 people who were hesitant about receiving the COVID-19 vaccine at the end of 2020, 32% were at least partially vaccinated by spring 2021, and 37% said they were likely to be, according to a research letter published today in JAMA Network …
Evidence growing for COVID antivirals to cut poor outcomes
WEB2 days ago · A recently published systematic review and meta-analysis found no evidence that the antiviral drugs nirmatrelvir/ritonavir (Paxlovid) and molnupiravir (Lagevrio) help prevent COVID-19 hospitalization, death, or persistent symptoms, results that the authors say call for reassessment of the role that oral antivirals play in the context of currently circulating SARS-CoV-2 variants and population ...